This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Dr. Samadi is a world-renowned prostate cancer expert and
robotic prostate surgeon. As the Vice Chairman, Department of Urology and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in
New York, Dr. Samadi has performed more than 4,500 successful robotic laparoscopic prostate surgeries. His
Samadi Modified Advanced Robotic Technique (SMART) surgery yields highly successful results in prostate cancer cure rate, as well as urinary continence and
sexual potency after surgery.
As a specialist in the diagnosis and treatment of urologic diseases and cancers, Dr. Samadi strongly encourages men to begin annual prostate screenings at age 50. African American men and men with a family history of prostate cancer are considered high risk for the disease and are advised to begin at age 40 or 45. The PSA is a simple blood test and the DRE is a painless physical exam of the prostate to check for irregularities.
Dr. Samadi calls the PSA test "an important first step" in diagnosing prostate cancer and other conditions such as benign prostatic hyperplasia (BPH). While the PSA test alone cannot confirm the presence of prostate cancer, an elevated PSA level indicates a potential issue. "When followed by a DRE and a prostate biopsy, as necessary, we can catch the disease very early and effectively eliminate it through surgery or other means," said Dr. Samadi. Localized prostate cancer is considered highly treatable through methods such as robotic prostatectomy surgery and radiation therapy.